Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
1,268
1,268 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- PRTX007Phase 21 trial
Primmune Therapeutics, Inc. · Melanoma Stage III
- PTT-4256Phase 21 trial
Pathios Therapeutics Pty Ltd · Advanced Solid Tumor
- PTT-936Phase 21 trial
Pyrotech Therapeutics, Inc. · Locally Advanced or Metastatic Solid Tumors
- PYX-201Phase 21 trial
Pyxis Oncology, Inc · Advanced Solid Tumors
- Q702Phase 21 trial
Qurient Co., Ltd. · Esophageal Cancer, Gastric Cancer, Hepatocellular Cancer
- QL1203Phase 21 trial
Qilu Pharmaceutical Co., Ltd. · Solid Tumor
- QLC1101Phase 21 trial
Qilu Pharmaceutical Co., Ltd. · Solid Tumor
- QLC5513Phase 21 trial
Qilu Pharmaceutical Co., Ltd. · Metastatic Solid Tumors
- QLF31907Phase 21 trial
Qilu Pharmaceutical Co., Ltd. · Advanced Malignant Neoplasm
- QLP2117Phase 21 trial
Qilu Pharmaceutical Co., Ltd. · Advanced Solid Tumor
- QLS1304Phase 21 trial
Qilu Pharmaceutical Co., Ltd. · Advanced ER+/HER2- Breast Cancer
- QLS2319Phase 21 trial
Qilu Pharmaceutical Co., Ltd. · Cancer Cachexia, Cancer Cachexia Syndrome
- RAD10118F-FPIAPhase 21 trial
Radiopharm Theranostics, Ltd · Brain Metastases From Solid Tumors
- RBP-01Phase 21 trial
ReBio Pharma · Uveal Melanoma
- RC278Phase 21 trial
RemeGen Co., Ltd. · Solid Tumors
- RC288Phase 21 trial
RemeGen Co., Ltd. · Solid Tumors
- RCZY690Phase 21 trial
Rongchang Pharmaceuticals Co., Ltd. · Advanced Malignant Solid Tumors
- REC-1245Phase 21 trial
Recursion Pharmaceuticals Inc. · Unresectable, Locally Advanced, Metastatic Cancers
- REC-7735Phase 21 trial
Recursion Pharmaceuticals Inc. · Solid Tumors
- REGN13089-M404-M2980Phase 21 trial
Regeneron · Advanced Solid Tumors
- REGN15505Phase 21 trial
Regeneron · Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)
- REGN21353Phase 21 trial
Regeneron · Metastatic Castration-Resistant Prostate Cancer, mCRPC
- REGN5668ubletamigPhase 21 trial
Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
- REM-422Phase 21 trial
Remix Therapeutics · Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma
- RemzistotugPhase 21 trial
GSK · Neoplasms, Head and Neck
- RG002Phase 21 trial
RinuaGene Biotechnology Co., Ltd. · Human Papillomavirus Associated Intraepithelial Neoplasia, Cervical Intraepithelial Neoplasia Grade 2/3, Human Papillomavirus Type 16 Infection
- RiMO-301Phase 21 trial
Coordination Pharmaceuticals, Inc. · Head Neck Cancer, Intratumoral Injection
- RLY-8161Phase 21 trial
Relay Therapeutics, Inc. · Advanced NRAS-Mutant Melanoma, Advanced NRAS-Mutant Solid Tumors, NRAS Mutation
- RNK05047Phase 21 trial
Ranok Therapeutics (Hangzhou) Co., Ltd. · Advanced Solid Tumor, DLBCL
- RO0091978Phase 21 trial
Roche (Genentech) · Metastatic Breast Cancer
- RO6874281Phase 21 trial
Roche (Genentech) · Pancreatic Adenocarcinoma
- RP-001Phase 21 trial
Recurv Pharma Inc · Advanced Malignancies, Oncology, Colorectal Cancer
- RR001Phase 21 trial
EIR Biotherapies s.r.l. · Locally Advanced Pancreatic Adenocarcinoma
- RS-113Phase 21 trial
R-Pharm International, LLC · Metastatic Castration-resistant Prostate Cancer
- RSO-021ThiostreptonPhase 21 trial
RS Oncology LLC · Malignant Pleural Effusion, Malignant Pleural Mesothelioma, Mesothelioma
- RT023Phase 21 trial
Shanghai Ruotuo Biosciences Co., Ltd. · Advanced Malignant Solid Tumours
- RT036Phase 21 trial
Shanghai Ruotuo Biosciences Co., Ltd. · Advanced Malignant Solid Tumours
- RV001VPhase 21 trial
RhoVac APS · Prostate Cancer Recurrent
- RVP-001Mn-PyC3A, mangaveratePhase 21 trial
Reveal Pharmaceuticals Inc. · Central Nervous System (CNS) Lesions, Brain Metastases, Brain Neoplasms
- RYZ711Phase 21 trial
RayzeBio, Inc. · Prostate Cancer (Adenocarcinoma), Adenocarcinoma of the Prostate, Metastatic Castration-resistant Prostate Cancer (mCRPC)
- RYZ801Phase 21 trial
RayzeBio, Inc. · Hepatocellular Carcinoma (HCC)
- S095018Phase 21 trial
Servier Bio-Innovation LLC · Non-small Cell Lung Cancer (NSCLC)
- S095024Phase 21 trial
Servier Bio-Innovation LLC · Non-small Cell Lung Cancer (NSCLC)
- S095035Phase 21 trial
Servier Bio-Innovation LLC · MTAP-deleted Solid Tumors
- SA53-OSPhase 21 trial
Lamassu Bio Inc · Solid Tumor
- SCG101Phase 21 trial
SCG Cell Therapy Pte. Ltd. · Hepatitis B Virus Related Hepatocellular Carcinoma, Hepatocellular Carcinoma Recurrent
- SCG142Phase 21 trial
SCG Cell Therapy Pte. Ltd. · HPV-Related Squamous Cell Carcinoma, HPV-Related Cervical Squamous Cell Carcinoma, HPV-Related Vulvar Squamous Cell Carcinoma
- selected combination of tinengotinibPhase 21 trial
TransThera Sciences (Nanjing), Inc. · Prostate Cancer (CRPC)
- Sequential EpirubicinPhase 21 trial
RemeGen Co., Ltd. · Breast Cancer
- SG1827Phase 21 trial
Hangzhou Sumgen Biotech Co., Ltd. · Advanced Solid Tumors
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.